Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT
J Clin Oncol. 2004 22 (6): 1103-9

PMID: 15020612 · DOI:10.1200/JCO.2004.08.158

MeSH Terms (20)

Adult Aged Aged, 80 and over Antineoplastic Agents Bronchoalveolar Lavage Fluid Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Epidermal Growth Factor Female Gefitinib Humans Logistic Models Lung Neoplasms Male Middle Aged Multivariate Analysis Protein-Tyrosine Kinases Quinazolines Retrospective Studies Smoking

Connections (1)

This publication is referenced by other Labnodes entities: